Janus Henderson Group’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-140,677
| Closed | -$6.7M | – | 2583 |
|
|
2023
Q3 | $6.7M | Sell |
140,677
-162,970
| -54% | -$7.76M | ﹤0.01% | 752 |
|
|
2023
Q2 | $29.1M | Sell |
303,647
-261,394
| -46% | -$25M | 0.02% | 497 |
|
|
2023
Q1 | $64.1M | Buy |
565,041
+2,626
| +0.5% | +$298K | 0.04% | 328 |
|
|
2022
Q4 | $63M | Sell |
562,415
-553,910
| -50% | -$62M | 0.05% | 325 |
|
|
2022
Q3 | $143M | Buy |
1,116,325
+847,805
| +316% | +$109M | 0.05% | 289 |
|
|
2022
Q2 | $18.4M | Sell |
268,520
-21,814
| -8% | -$1.5M | 0.01% | 582 |
|
|
2022
Q1 | $41.3M | Buy |
290,334
+37,579
| +15% | +$5.35M | 0.02% | 552 |
|
|
2021
Q4 | $42.1M | Buy |
252,755
+35,815
| +17% | +$5.97M | 0.02% | 601 |
|
|
2021
Q3 | $30.2M | Buy |
216,940
+26,653
| +14% | +$3.71M | 0.01% | 691 |
|
|
2021
Q2 | $90.8M | Buy |
190,287
+7,890
| +4% | +$3.76M | 0.04% | 398 |
|
|
2021
Q1 | $75.1M | Buy |
182,397
+50,133
| +38% | +$20.6M | 0.03% | 443 |
|
|
2020
Q4 | $64.8M | Buy |
132,264
+36,560
| +38% | +$17.9M | 0.03% | 475 |
|
|
2020
Q3 | $54.2M | Buy |
+95,704
| New | +$54.2M | 0.03% | 480 |
|